14
Engagement within the new system Paul McManus, Lead Pharmacist | Specialised Commissioning

Engagement within the new system

Embed Size (px)

Citation preview

Page 1: Engagement within the new system

Engagement within the new systemPaul McManus, Lead Pharmacist | Specialised Commissioning

Page 2: Engagement within the new system

Engagement within the new systemPaul McManusLead pharmacist - specialised servicesSouth Yorkshire and Bassetlaw Area Team

ABPI Regional event June 2013

Page 3: Engagement within the new system

NHS | Presentation to [XXXX Company] | [Type Date]3

Page 4: Engagement within the new system

Opportunities for engagement

Product specificNational

• research

• pipeline

• commissioning

• value

• price

• placement4

Local• implementation

• price

• priorities

• problems

Page 5: Engagement within the new system

Medicines optimisation

Medicines still most common therapeutic intervention and biggest cost after staff,

but, for example:

•30 to 50% not taken as intended

•Patients have insufficient supporting information

• UK Literature suggests 5 to 8% of hospital admissions due to preventable adverse effects of medicines

•Medication errors across all sectors and age groups at unacceptable levels

•Medicines wastage in primary care: £300M pa with £150M pa avoidable

•Relatively little effort towards understanding clinical effectiveness of medicines in real practice

•The threat of antimicrobial resistance

Source: NHS Prescription Services of the NHS Business Service Authority

Page 6: Engagement within the new system

National Reporting and Learning System for England and WalesTypes of incidents 2005-10

Cousins D, Gerrett D, Warner B. Br J Clin Pharmacol. 2012

Page 7: Engagement within the new system

NRLS in England and Wales medication incident reports 2005 - 10

Cousins D, Gerrett D, Warner B. Br J Clin Pharmacol. 2012

Page 8: Engagement within the new system

NRLS – who is reporting incidents?

8 Cousins D, Gerrett D, Warner B. Br J Clin Pharmacol. 2012

Page 9: Engagement within the new system

NRLS – Critical medicines

Cousins D, Gerrett D, Warner B. Br J Clin Pharmacol. 2012

NRLS – Critical medicines

Page 10: Engagement within the new system

NRLS – Error category

Cousins D, Gerrett D, Warner B. Br J Clin Pharmacol. 2012

Page 11: Engagement within the new system

Medicines Optimisation Principles

Page 12: Engagement within the new system

A strategy might include…• Patient engagement • Collaborative working across health economies• Improving outcomes• Value for money • Partnership with industry• Medicines pathway• Safety and assurance

12

Information and technology

Page 13: Engagement within the new system

What can we do?

•Be an active commissioner

•Ensure contact at right level and make meetings productive for all

• Look for ways to best use skills and resources available

•Think beyond individual products

•Start talking13

Page 14: Engagement within the new system

Engagement within the new [email protected]

14